These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10397042)

  • 21. Extended hormone replacement: who should get it, and for how long?
    Langer RD; Barrett-Connor E
    Geriatrics; 1994 Dec; 49(12):20-4; 29. PubMed ID: 7982582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
    Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone replacement therapy in postmenopausal women: utilization of health care resources by new users.
    Thorp JM; Gavin NI; Ohsfeldt RL
    Am J Obstet Gynecol; 2001 Aug; 185(2):318-26. PubMed ID: 11518885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
    Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
    Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997.
    Bakken K; Eggen AE; Lund E
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):850-6. PubMed ID: 15315597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of hormone replacement therapy in Washington State: is prevention being put into practice?
    Saver BG; Taylor TR; Woods NF
    J Fam Pract; 1999 May; 48(5):364-71. PubMed ID: 10334613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The HRT misuse and osteoporosis epidemic: a possible future scenario.
    Gambacciani M; Ciaponi M; Genazzani AR
    Climacteric; 2007 Aug; 10(4):273-5. PubMed ID: 17653953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.
    Guay MP; Dragomir A; Pilon D; Moride Y; Perreault S
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):17-27. PubMed ID: 16794994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of hormone replacement therapy among cardiac patients at a Canadian academic centre.
    Wise MR; Stewart DE; Liu P; Abramson BL
    CMAJ; 1999 Jul; 161(1):33-6. PubMed ID: 10420861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The changing view of hormone replacement therapy.
    Vogel RA
    Rev Cardiovasc Med; 2003; 4(2):68-71. PubMed ID: 12776015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone replacement therapy and cardiovascular health in the United States.
    Shetty KD; Vogt WB; Bhattacharya J
    Med Care; 2009 May; 47(5):600-6. PubMed ID: 19319001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Olsson HL; Ingvar C; Bladström A
    Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is hormone replacement therapy prescribed for postmenopausal diabetic women?
    Feher MD; Isaacs AJ
    Br J Clin Pract; 1996 Dec; 50(8):431-2. PubMed ID: 9039712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone replacement therapy. Indications, benefits and risk.
    Davis S
    Aust Fam Physician; 1999 May; 28(5):437-45. PubMed ID: 10376367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selecting patients for HRT: positive indications.
    Ross D; Whitehead MI
    Br J Clin Pract; 1995; 49(2):92-4. PubMed ID: 7779652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hormone replacement therapy and prevention of postmenopausal cardiovascular diseases].
    Grand A
    Ann Cardiol Angeiol (Paris); 1998; 47(7):481-7. PubMed ID: 9772970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Menopause. Hormone substitution therapy and prevention of cardiovascular risk].
    Grio R; Cellura A; Porpiglia M; Geranio R; Piacentino R
    Minerva Ginecol; 1998; 50(7-8):329-31. PubMed ID: 9808958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Osteoporosis. Knowledge and attitudes of the Norwegian population].
    Joakimsen RM; Søgaard AJ; Tollan A; Magnus JH
    Tidsskr Nor Laegeforen; 1996 Jun; 116(17):2013-6. PubMed ID: 8766643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescription of hormone replacement therapy in postmenopausal women with renal failure.
    Stehman-Breen CO; Gillen D; Gipson D
    Kidney Int; 1999 Dec; 56(6):2243-7. PubMed ID: 10594801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.